Study guide
5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis
AACN Cardiac Medicine Certification CMC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview and the CMC Test Plan
1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them
2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease
2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy
3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease
3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup
4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions
4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation
5 Chapter 5: Vascular Conditions and Vascular Interventions
5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications
6 Chapter 6: Shock States and Mechanical Circulatory Support
6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD
7 Chapter 7: Cardiac Procedures and Structural Heart Interventions
7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications
8 Chapter 8: Cardiovascular Pharmacology
8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure
9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary
9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients
10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral
10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients
11 Chapter 11: Monitoring and Diagnostics
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography
12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions
12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease
5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis
Key Takeaways Explain This Topic AI
Proximal deep vein thrombosis (popliteal vein or above) carries the highest pulmonary embolism risk and always gets therapeutic anticoagulation; isolated distal calf thrombosis in a low-risk asymptomatic patient may instead be followed with serial compression ultrasound at about 2 weeks.
Apixaban for acute venous thromboembolism is 10 mg PO twice daily for 7 days then 5 mg twice daily; rivaroxaban is 15 mg twice daily for 21 days then 20 mg daily with food. Dabigatran 150 mg twice daily and edoxaban 60 mg daily both require a 5-10 day parenteral lead-in.
D-dimer has almost no diagnostic value in the cardiac ICU because heart failure, recent MI or surgery, sepsis, IABP, ECMO and age all elevate it; it excludes venous thromboembolism only when pretest probability is low.
Phlegmasia cerulea dolens (massive iliofemoral thrombosis with a tense, cyanotic, painful limb and failing arterial inflow) is a limb- and life-threatening emergency requiring immediate IV heparin plus catheter-directed or pharmacomechanical thrombectomy.
Dual antiplatelet therapy is never venous thromboembolism prophylaxis: a post-PCI patient on aspirin plus ticagrelor still needs mechanical or pharmacologic prophylaxis, and intermittent pneumatic compression is contraindicated by an existing acute DVT, severe limb ischemia, open wounds, or recent fasciotomy.
Last updated: August 2026
Why Venous Thrombosis Is a Cardiac-ICU Problem
Test-plan item I.B.2 sits inside Cardiovascular Conditions, and the CMC exam approaches venous thromboembolism (VTE) — the umbrella term covering deep vein thrombosis (DVT) and pulmonary embolism (PE) — as a complication the cardiac nurse is expected to prevent, detect early, and then manage anticoagulation for. The cardiac ICU concentrates every arm of Virchow's triad on the same patient simultaneously, which is why VTE incidence here runs far above the general medical ward.
Virchow's Triad in the Cardiac Patient
Triad element Cardiac-specific drivers
Venous stasis Low cardiac output and elevated central venous pressure in decompensated heart failure; post-procedure bed rest after femoral access; immobility on mechanical ventilation or intra-aortic balloon pump (IABP); atrial fibrillation with atrial stasis; obesity and right heart failure with venous congestion
Endothelial injury Femoral and radial sheaths; central venous and pulmonary artery (PA) catheters; extracorporeal membrane oxygenation (ECMO) cannulas; transvenous pacing leads; peripherally inserted central catheters (PICCs); repeated venipuncture
Hypercoagulability Systemic inflammation after myocardial infarction and after cardiac surgery; sepsis; malignancy; heparin-induced thrombocytopenia (HIT); estrogen therapy; inherited thrombophilia; the acute-phase response following any cardiac intervention
Layer on the routine cardiac-ICU practice of prolonged supine bed rest after femoral access and the habit of holding prophylaxis for procedures, sheath removal, or an epidural, and you have the scenario the exam loves: prophylaxis was suspended 48 hours ago and nobody restarted it.
Anatomy Determines Urgency
Proximal DVT — popliteal, femoral, common femoral or iliac vein. Highest risk of PE and of post-thrombotic syndrome. Always treated with therapeutic anticoagulation.
Distal (calf) DVT — confined to the peroneal, posterior tibial or anterior tibial veins. Roughly 15% propagate proximally. Anticoagulate the symptomatic patient with low bleeding risk; in an asymptomatic low-risk patient, serial compression ultrasound at about 2 weeks is an accepted alternative to anticoagulation.
Upper-extremity DVT (UEDVT) — axillary, subclavian, brachiocephalic. In cardiac patients this is overwhelmingly catheter-associated (PICC, central line, PA catheter, pacer or defibrillator leads) rather than the effort-related Paget-Schroetter type. It presents as unilateral arm swelling, a dull neck or shoulder ache, and dilated superficial chest-wall collateral veins. Anticoagulate; a functioning catheter that is still needed can usually stay in place.
The conversion event is what kills. Sudden dyspnea, pleuritic chest pain, unexplained sinus tachycardia, hypoxemia, or syncope in a patient with a known DVT is a pulmonary embolism until proven otherwise, and in a patient with marginal right ventricular reserve after an inferior MI it is poorly tolerated.